DETERMINATION OF TUMOUR MARKER PSA AND RFTs IN PROSTATIC CANCER PATIENTS. Review Journal of Neurological & Medical Sciences Review, [S. l.], v. 4, n. 5, p. 223–231, 2026. DOI: 10.63075/95pc9k34. Disponível em: https://nmsreview.org/index.php/rjnmsr/article/view/887. Acesso em: 13 may. 2026.